Offer - Urjas Oil for just ₹ 1
Cefomek is an allopathic medicine The correct dosage of Cefomek depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Cefomek is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Is the use of Cefomek safe for pregnant women?
Pregnant women may get mild side effects from Cefomek.
Is the use of Cefomek safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Cefomek. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Cefomek on the Kidneys?
There can be some harmful effects on your kidneys after taking Cefomek. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cefomek on the Liver?
Cefomek may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Cefomek on the Heart?
Very few cases of side effects of Cefomek on the heart have been reported.
Cefomek should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cefomek unless your doctor advises you to do so -
Is this Cefomek habit forming or addictive?
Cefomek is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Cefomek does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, the use of Cefomek is considered safe.
Is it able to treat mental disorders?
There is no benefit of taking Cefomek for mental disorders.
Interaction between Food and Cefomek
It is safe to take Cefomek with food.
Interaction between Alcohol and Cefomek
Due to lack of research, there is no information about the side effects of taking Cefomek with alcohol.
Avoid taking Cefomek with azithromycin, because it can cause heart-related problems. However, if you are experiencing any discomfort after consuming these two medicines at the same time then do not hesitate to inform your doctor.
Yes, Cefomek can cause stomach upset if taken on an empty stomach. It is a common side effect of this drug. Please inform your doctor if you are experiencing severe stomach upset after taking this medicine.
Discontinuing Cefomek in between may promote resistance to bacteria which may result in a relapse of the infection. You are recommended to complete the 7 - 14 days course even after getting symptomatic relief. Incase you feel any discomfort such as breathing difficulties and skin reactions while taking this medicine please inform your doctor immediately.
Yes, Cefomek can be taken for a cough, if it is associated with infection caused by bacteria. However, if a cough gets severe and does not subside after taking this drug. Do consult a doctor for the right treatment.
Yes, you can use Cefomek to treat pneumonia. It effectively relieves pneumonia, especially in children. Treatment can vary from patient to patient, so you must consult your doctor before consuming this medicine for pneumonia.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
